Oxford Biomedica and Santen enter R&D collaboration
LONDON: Oxford, UK and Osaka Japan-Oxford Biomedica, a leading gene and cell therapy group, and Santen Pharmaceutical Co., Ltd. (Santen), the market leader for prescription ophthalmic pharmaceuticals in Japan with…